P. Ghelani

Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study

V. Lorusso, I. Durán, D. Lüftner, 2013, Journal of medical economics.

Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study

V. Lorusso, I. Durán, D. Lüftner, 2014, SpringerPlus.

Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational Study

V. Lorusso, I. Durán, D. Lüftner, 2014, Journal of clinical medicine.

Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy: A Randomized Open-Label Trial

C. Benhamou, N. Binkley, C. Recknor, 2013, Obstetrics and Gynecology.

A phase III open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results.

J. Szepietowski, K. Kingo, A. Reich, 2021, Journal of the American Academy of Dermatology.

PCN115 Cost of Skeletal-Related Events (SREs) in Patients with Bone Metastases to solid Tumours Based on the Health Resource Utilisation (HRU) Collected in a Prospective European Multinational Observational Study

I. Durán, D. Lüftner, A. Bahl, 2011 .